# Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

> clinical trial · VERIFIED · 2026-06-17

Status: RECRUITING · Sponsor: National Cancer Institute (NCI) · Condition: Advanced Malignant Solid Neoplasm

- Company: National Cancer Institute (NCI)
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT05564377

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.